78
Participants
Start Date
December 31, 2006
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Sorafenib
Sorafenib
RAD001
RAD001
South Carolina Oncology Associates, PA, Columbia
Spartanburg Regional Medical Center, Spartanburg
Wellstar Cancer Research, Marietta
Northeast Georgia Medical Center, Gainesville
Florida Hospital Cancer Institute, Orlando
Tennessee Oncology, PLLC, Nashville
Baptist Hospital East, Louisville
Norton Cancer Institute, Louisville
Oncology Hematology Care, Cincinnati
Research Medical Center, Kansas City
Hematology Oncology Associates of Northern NJ, Morristown